Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
25 Oct 2016 04:40 PM
RNS
Director/PDMR Shareholding
10 Oct 2016 07:21 AM
RNS
Publication of RetinoStat® (OXB-201) Phase I study
06 Oct 2016 09:24 AM
RNS
Holding(s) in Company
05 Oct 2016 10:17 AM
RNS
Holding(s) in Company
04 Oct 2016 11:57 AM
RNS
Holding(s) in Company
04 Oct 2016 08:16 AM
RNS
Admission to Trading and Total Voting Rights
29 Sep 2016 12:27 PM
RNS
Result of General Meeting and Directors Dealing
26 Sep 2016 11:00 AM
RNS
Director/PDMR Shareholding
13 Sep 2016 03:07 PM
RNS
Publication of Prospectus
13 Sep 2016 07:01 AM
RNS
FUNDRAISING OF £10 MILLION
13 Sep 2016 07:00 AM
RNS
INTERIM RESULTS FOR 6 MONTHS ENDED 30 JUNE 2016
01 Sep 2016 10:47 AM
RNS
Total Voting Rights
25 Aug 2016 02:22 PM
RNS
Director/PDMR Shareholding
02 Aug 2016 04:35 PM
RNS
Price Monitoring Extension
02 Aug 2016 09:32 AM
RNS
Total Voting Rights
28 Jul 2016 07:00 AM
RNS
Manufacturing Approvals and Expansion Completed
25 Jul 2016 09:56 AM
RNS
Director/PDMR Shareholding
08 Jul 2016 12:02 PM
RNS
Price Monitoring Extension
04 Jul 2016 09:14 AM
RNS
Block Listing Return
04 Jul 2016 09:12 AM
RNS
Total Voting Rights
28 Jun 2016 04:40 PM
RNS
Second Price Monitoring Extn
28 Jun 2016 04:35 PM
RNS
Second Price Monitoring Extn
28 Jun 2016 12:07 PM
RNS
Second Price Monitoring Extn
28 Jun 2016 12:02 PM
RNS
Price Monitoring Extension
27 Jun 2016 10:37 AM
RNS
Director/PDMR Shareholding
22 Jun 2016 12:07 PM
RNS
Second Price Monitoring Extn
22 Jun 2016 12:02 PM
RNS
Price Monitoring Extension
16 Jun 2016 04:40 PM
RNS
Second Price Monitoring Extn
16 Jun 2016 04:35 PM
RNS
Price Monitoring Extension
15 Jun 2016 12:07 PM
RNS
Second Price Monitoring Extn
15 Jun 2016 12:02 PM
RNS
Price Monitoring Extension
07 Jun 2016 01:14 PM
RNS
Oxford BioMedica Annual General Meeting
07 Jun 2016 07:00 AM
RNS
New Non-Exclusive LentiVector Licence with MolMed
06 Jun 2016 03:29 PM
RNS
OXB to Present at Jefferies Healthcare Conference
02 Jun 2016 10:05 AM
RNS
R&D Partnership with Green Cross LabCell
02 Jun 2016 09:30 AM
RNS
Total Voting Rights
24 May 2016 10:08 AM
RNS
Director/PDMR Shareholding
18 May 2016 07:00 AM
RNS
Deferred Bonus Plan and LTIP Option Grants
17 May 2016 07:00 AM
RNS
Oxford BioMedica Appoints Corporate Broker
16 May 2016 09:23 AM
RNS
Director/PDMR Shareholding
16 May 2016 09:16 AM
RNS
Director/PDMR Shareholding
12 May 2016 07:00 AM
RNS
Oxford BioMedica Board Change
06 May 2016 12:21 PM
RNS
Director/PDMR Shareholding
06 May 2016 07:00 AM
RNS
Long-Term Expression of LentiVector
05 May 2016 05:50 PM
RNS
2015 Annual Report and Accounts & AGM Notification
05 May 2016 09:22 AM
RNS
Director/PDMR Shareholding
04 May 2016 08:48 AM
RNS
Director/PDMR Shareholding
03 May 2016 12:57 PM
RNS
Director/PDMR Shareholding
03 May 2016 09:25 AM
RNS
Total Voting Rights
29 Apr 2016 01:35 PM
RNS
Director Shareholding

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings